Michigan Medicine opens adult and pediatric COVID-19 long haul clinics

Two multidisciplinary teams band together to create a coordinated approach to studying the disease’s long-term outcomes in vulnerable adult and pediatric populations.

Authors | Jordyn Imhoff | Mary Masson

Patients hospitalized for COVID-19 are experiencing a broad spectrum of long-term multi-organ issues involving pulmonary, cardiovascular, kidney, metabolic, mood and neurologic complications. Most recently, it’s become apparent that the risk of developing these complications is high even in patients who only experienced mild forms of COVID-19.

Now, to better serve this population, Michigan Medicine is establishing clinics to provide post-discharge care to both adults and pediatric patients experiencing these long-term post COVID symptoms and complications.

More than 1,500 adult patients have been hospitalized with severe COVID-19 at Michigan Medicine, with more than two-thirds having diabetes. Meanwhile, doctors at C.S. Mott Children’s Hospital have seen more than a dozen cases of kids and teens with persistent COVID symptoms, including respiratory issues and fatigue, months after even mild cases of COVID.

“There is an urgent need to better understand the long-term complications of COVID-19 and provide specialized care for high-risk groups of patients’,” says Michigan Medicine endocrinologist Rodica Pop-Busui, M.D., Ph.D., director of the adult clinic.

“The COVID-19 pandemic has affected all of us, and of course those infected by the virus. Data suggests that 10-20% of those previously infected and over the acute phase of the infection have lingering symptoms that could be organ-based damage or a syndrome called post-acute sequelae of COVID-19 (PASC),” says John M. Carethers, M.D., M.A.C.P., chair of the department of Internal Medicine. “Dr. Busui has led assembling an outstanding multidisciplinary team of experts that cross multiple medical disciplines to create a one-stop evaluation and treatment approach clinic for patients afflicted with PASC.”

The adult clinic, formally named the Multidisciplinary Post COVID-19 Clinic, operates under a mixed in-person – virtual care model, and is located at Domino’s Farms (4000 Ave Maria Dr. Lobby C, Suite 1300). The in-person appointments are held on Friday afternoons.

A large proportion of the patients who have been hospitalized at Michigan Medicine are new to the institution and don’t have established care, highlighting an unmet need for post-discharge care.

Eligible clinic patients must:

  • Be 18 years and older with a history of lab-confirmed COVID-19.
  • Be referred by a primary care provider or inpatient provider at discharge.
  • Have a comorbid diabetes, prediabetes, obesity, thyroid or adrenal diagnosis with continuation of symptoms post COVID-19, including fatigue, shortness of breath, joints and muscles pain, weakness, dizziness, chest pain and memory problems.

“While our goal is to offer our clinic services to all patients hospitalized with COVID-19, we’re initially targeting patients with diabetes or obesity given their high-risk status and the significant disturbances in blood glucose attributed to COVID-19,” says Pop-Busui.

The patient’s first visit will include consultations with endocrinology, physical medicine and rehabilitation and neuropsychology. In addition, there are specific criteria for laboratory and other tests that will guide personalized referrals to selective virtual specialties based on how each patient presents in clinic, including cardiology, nephrology, neurology, pulmonary, podiatry and infectious disease will be consulted as needed. Social workers and certified diabetes educators will also be onsite as ancillary providers.

All consenting patients are also invited to participate in research, in a true integration of cutting-edge research into the clinical care where patients will undergo a comprehensive battery of tests and questionnaires, with labs and imaging provided on-site. Then, patients will be prescribed a treatment plan by the pre-designated subspecialties’, with follow-up appointments at three and six months.

“Given the large number of patients that have contracted COVID-19 in these several waves and the extent of the post-acute sequelae, the demand and community need for these services is expanding, and it falls in line with Michigan Medicine’s mission that we are at the forefront to meet that need,” says Michigan Medicine cardiologist Salim Hayek, M.D., Ph.D., co-director of the adult clinic and COVID-19 researcher.

“At Michigan Medicine, we aim to not only diagnose and better the patient, but to continually learn from patients with PASC so that we can apply that knowledge to future patients, and improve the care of those participating with us in clinical research and in their own clinical care,” says Carethers. “We will assess, provide the best care, and learn from this unfortunate affliction to minimize its occurrence going forward.”

Pediatric Post-COVID Syndrome Clinic

The pediatric Post-COVID Syndrome Clinic is located at Mott where Michigan’s top-ranked pediatric subspecialties will assist children, adolescents and teens coping with the long-term effects of COVID-19 or multisystem inflammatory syndrome in children (MIS-C).

Eligible clinic patients must:

  • Be under the age of 21 with a history of lab-confirmed COVID-19.
  • Be referred by a primary care provider. 
  • Have a continuation of symptoms, including fatigue, shortness of breath, joint pain, chest pain, and cough that persist for more than two months (60 days) post COVID-19.
  • Have no other exposures or explanations for the new or worsening symptoms.

“We’ve seen many children who have breathing issues and other lingering symptoms long after an initial infection,” says Carey Lumeng, M.D., Ph.D., a Mott pediatric pulmonologist who leads the Mott post-COVID clinic.

“Most of these initial infections were mild and didn’t require hospitalization or even outpatient care. Our goal is to better understand this phenomenon in young people and ensure that patients see the right group of specialists to address their specific symptoms.”  

Patients will benefit from care coordination with Mott’s pediatric subspecialists and patients’ primary care providers. The patient’s first visit will either be in person or virtual to assess the symptoms, the need for coordinated care, and the need for additional testing.  Experts in pediatric pulmonology, pediatric cardiology, pediatric psychology, and pediatric physical medicine and rehabilitation will review the cases and come up with an assessment and treatment plan.

Similar to the adult clinic, the pediatric clinic will offer virtual and in-person visits with the option to participate in research studies on the long-term effects of COVID-19 in children.

To learn more or make an appointment at the adult Multidisciplinary Post COVID-19 Clinic, visit michmed.org/postCOVIDclinic. To learn more about the pediatric Post-COVID Syndrome Clinic, visit mottchildren.org/postCOVIDclinic.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Featured News & Stories The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Cannabis and psychedelics: stigmatized substances or powerful therapeutics?
Today on The Fundamentals is Dr. Kevin Boehnke, research assistant professor in the Department of Anesthesiology and the Chronic Pain and Fatigue Research Center. His current research focuses on therapeutic applications of cannabis and psychedelics. His goal is to rigorously assess appropriate use of these substances and to help address the public health harms caused by their criminalization.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Treating Diabetes & Weight: The Ozempic & Wegovy Effect
Today on The Fundamentals, our guest Dr. Martin Myers, Director of the U-M Elizabeth Weiser Caswell Diabetes Institute, discusses diabetes research in the context of Ozempic, Wegovy, and other drugs that are changing how people think about weight loss. You can learn more about Dr. Myers here, and you can follow the department of molecular and integrative physiology @UMPhysiology on X.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
If they don't give up, how can I give up?
Today on The Fundamentals is Dr. Maria Castro, the R.C. Schneider collegiate professor of neurosurgery, and a professor of cell and developmental biology at the University of Michigan Medical School. Her research program aims to develop immunotherapies for primary and metastatic brain cancer, studying basic immune biology mechanisms leading to clinical implementation. She has been inducted into the American Association for the Advancement of Sciences, the Latin American Academy of Sciences, and the American Institute for Medical and Biological Engineering College of Fellows. She has won numerous awards for her contributions to basic science and cancer research and is a diversity ambassador for the Cancer Biology Graduate Training Program. You can learn more about Dr. Castro here, and you can follow her @castro2355_mg, the Rogel Cancer Center @UMRogelCancer, the department of neurosurgery @umichneuro, Michigan Neurscience Institute @UM_MNI and the department of cell and developmental biology @UMCDB on X
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Addiction is a lifelong disease and not a moral failing
On today’s The Fundamentals is Dr. Brummett, Professor at the University of Michigan where he serves as the Senior Associate Chair for Research in the Department of Anesthesiology. He has more than 280 publications, including articles in top journals such as JAMA, JAMA Surgery, Anesthesiology, and Annals of Surgery. He is the Co-Director of the Opioid Prescribing Engagement Network or OPEN at the University of Michigan, which aims to apply a preventative approach to the opioid epidemic in the US through appropriate prescribing after surgery, dentistry and emergency medicine. Moreover, he is the Co-Director of the cross-campus Opioid Research Institute, which was launched in the spring of 2023. He leads multiple NIH grants studying these concepts and receives funding from the Michigan Department of Health and Human Services, SAMHSA, CDC, and multiple foundations. You can learn more about Dr. Brummett here, and you can follow Dr. Brummett @drchadb and the department of anesthesiology @UMichAnesthesia on X.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
From Patients to Progress: Advancing Autoimmune Research
Today on The Fundamentals, our guest is Dr. Michelle Kahlenberg, an Associate Professor of Internal Medicine and Dermatology, the Giles Bole and Dorothy Mulkey Research Professor of Rheumatology and the Vice Chair for Basic and Translational Research in Internal Medicine. Her clinical work is centered on the care of patients with lupus, including those with refractory skin disease. In addition to running her lab, she's an active member of the Immunology Training Program and has received national recognition for her research.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Can AI Make Us Healthier Humans?
Dr. Jody Platt. She is an Associate Professor of Learning Health Sciences at the University of Michigan Medical School. Trained in medical sociology and health policy, her research focuses on issues at the intersection of informatics and ethics. She is interested in understanding what makes data-driven health trusted, and the pathways for earning, achieving, and sustaining trust across stakeholders. Dr. Platt is the Academy Health and ABIM Foundation Senior Scholar in Residence advising on issues of measuring and building trust.